About Dravya Pharmaceutical Private Limited
Data last updated:
Dravya Pharmaceutical Private Limited is a private limited company based in Delhi, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 05 March 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U51909DL2018PTC330275. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sachin Singhal and Pooja Singhal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at A56 Gokuldham Building Rani Bagh Rishi Nagar Delhi, Delhi, India – 110034.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.72 Lakh, a decline of 95% compared to the previous year. For the same year it recorded a net loss of ₹1.2 Lakh (net margin -25.5%) and EBITDA of -₹1.19 Lakh (EBITDA margin -25.3%). Revenue has declined at a compounded annual rate (CAGR) of 29% over three years and 32% over five years.
Court records list 1 case involving the company, including 1 filed against it.
For more details, the company can be reached via its website dravyapharmaceutical.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressA56 Gokuldham Building Rani Bagh Rishi Nagar Delhi, Delhi, India – 110034
- IndustryHealthcare, Ayurvedic Products & Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Dravya Pharmaceutical Private Limited
The main business activity of Dravya Pharmaceutical is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Dravya Pharmaceutical Private Limited FY 2025 filings available
Dravya Pharmaceutical Private Limited reported revenue of ₹4.72 Lakh (down 95% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Dravya Pharmaceutical Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 32% over five years, including a 95% fall in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Dravya Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹1.19 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹1.2 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Dravya Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -25.3% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -25.5% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Dravya Pharmaceutical are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Dravya Pharmaceutical Private Limited
Dravya Pharmaceutical Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anvik Biotech Private Limited | ₹4.8 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | Rai, Haryana, India |
| Arka Fertilife Private Limited | ₹4.8 Lakh (FY 2023) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Gen Med Health Formulations Private Limited | ₹4.78 Lakh (FY 2025) | •••• | •••• | 173.0% | •••• | Telangana, India |
| MPS Pharmaa Limited Listed | ₹4.77 Lakh (FY 2025) | •••• | •••• | -49.0% | •••• | Gurgaon, Haryana, India |
| Acg Cellulose Private Limited | ₹4.76 Lakh (FY 2025) | •••• | •••• | 632.0% | •••• | Mumbai, Maharashtra, India |
| Dravya Pharmaceutical Private Limited this company | ₹4.72 Lakh (FY 2025) | •••• | •••• | -95.0% | •••• | Delhi, India |
| Aadiyogi Wellness Private Limited | ₹4.7 Lakh (FY 2023) | •••• | •••• | •••• | Haridwar, Uttarakhand, India | |
| Vipran Food and Pharmaceuticals Private Limited | ₹4.68 Lakh (FY 2024) | •••• | •••• | -53.0% | •••• | Shiroli, Maharashtra, India |
| Lexica Drugs and Formulations Private Limited | ₹4.66 Lakh (FY 2025) | •••• | •••• | 15.0% | •••• | Agra, Uttar Pradesh, India |
| Shanti Medi Treat Pvt Ltd | ₹4.64 Lakh (FY 2025) | •••• | •••• | 5.0% | •••• | Howrah, West Bengal, India |
| Daisy Formulations Private Limited | ₹4.59 Lakh (FY 2024) | •••• | •••• | 15.0% | •••• | Narsinghpur, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Dravya Pharmaceutical by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Dravya Pharmaceutical Private Limited
Dravya Pharmaceutical Private Limited is audited by VINAY I AGGARWAL & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| VINAY I AGGARWAL & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Dravya Pharmaceutical Private Limited
Dravya Pharmaceutical has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sachin Singhal | Director | 05 Mar 2018 | 8 Years 7 Months | Current |
| Pooja Singhal | Director | 05 Mar 2018 | 8 Years 7 Months | Current |
Ownership and Shareholding of Dravya Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Dravya Pharmaceutical Private Limited
Dravya Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Dravya Pharmaceutical Private Limited
Dravya Pharmaceutical Private Limited has 1 court case on record: 1 filed against it. All case is disposed. Status as checked on 02 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 0 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Shahdara, Delhi | Commercial suit | Filed against the company by an individual | Disposed |
Full case history
All 1 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Dravya Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to Dravya Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Dravya Pharmaceutical Private Limited
Dravya Pharmaceutical Private Limited has 3 board changes on record since 2018: 2 appointments and 1 cessation. The latest: Ajay Singhal ceased to be Director on 20 Sep 2019.
Credit Ratings, Litigation & Regulatory Alerts for Dravya Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Dravya Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Dravya Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Dravya Pharmaceutical Private Limited
Dravya Pharmaceutical has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Dravya Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dravya Pharmaceutical Private Limited
Dravya Pharmaceutical is an active private limited company based in Delhi, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 05 March 2018 (8+ years old) and is registered under CIN U51909DL2018PTC330275.
Dravya Pharmaceutical reported revenue of ₹4.72 Lakh for FY 2025 (down 95% YoY).
Dravya Pharmaceutical has 2 current directors:
- Sachin Singhal - Director
- Pooja Singhal - Director
Dravya Pharmaceutical reported a net loss of ₹1.2 Lakh (net margin -25.5%) and EBITDA of -₹1.19 Lakh (EBITDA margin -25.3%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Dravya Pharmaceutical is -29% over three years and -32% over five years. In the latest year (FY 2025) revenue fell 95%. CAGR is the steady yearly rate that links the first and the last year.
No. Dravya Pharmaceutical has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Dravya Pharmaceutical is U51909DL2018PTC330275. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dravya Pharmaceutical has 1 court case on record: 1 filed against it.
Dravya Pharmaceutical was incorporated on 05 March 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Dravya Pharmaceutical by revenue are Anvik Biotech Private Limited, Arka Fertilife Private Limited, Gen Med Health Formulations Private Limited, MPS Pharmaa Limited, Acg Cellulose Private Limited and 5 more, all in the Pharma industry (Formulations).
Ajay Singhal ceased to be Director on 20 Sep 2019. Pooja Singhal was appointed as Director on 05 Mar 2018. Sachin Singhal was appointed as Director on 05 Mar 2018.